© 2020 MJH Life Sciences and Neurology Live. All rights reserved.
© 2020 MJH Life Sciences™ and Neurology Live. All rights reserved.
October 14, 2020
The drug, marketed as Wakix, was previously approved for the treatment of excessive daytime sleepiness in adults with narcolepsy.
October 13, 2020
The device is the first FDA-approved trigeminal nerve stimulator for migraine treatment available without a prescription.
August 15, 2020
The subcutaneous injection is indicated in patients with anti-aquaporin-4 antibody positive NMOSD.
August 13, 2020
The drug is indicated in patients with a confirmed mutation in the DMD gene that is amenable to exon 53 skipping.